Han, Xue
Zhang, Xi
Zhong, Liling
Liu, Ying
Gong, Lifen
Zhang, Jikai
Wang, Hai
Chen, Qingsong
Funding for this research was provided by:
Chinese Foundation for Hepatitis Prevention and Control grant (YGFK20220066)
Article History
Received: 27 October 2023
Accepted: 6 May 2024
First Online: 27 September 2024
Declarations
:
: The study protocol was approved by the Medical Ethics Review Board of the School of Public Health within Guangdong Pharmaceutical University (Guangzhou, China). The study protocol complied with the Declaration of Helsinki 1964 and its later amendments. All participants’guardians provided written informed consent.
: All authors are in agreement with the content of the manuscript. All participants’guardians provided written informed consent.
: The authors declare no competing interests.